STOCK TITAN

Colgate Palmolive Co Stock Price, News & Analysis

CL NYSE

Company Description

Colgate-Palmolive Company (CL) is one of the world's largest consumer products corporations, manufacturing and marketing oral care, personal care, home care, and pet nutrition products across more than 200 countries and territories. Founded in 1806 and headquartered in New York City, the company trades on the New York Stock Exchange and has built a portfolio of globally recognized brands that reach hundreds of millions of households daily.

The company operates through four primary business segments that generate revenue through distinct product categories and geographic markets. Oral Care represents the company's largest and most profitable division, encompassing toothpaste, toothbrushes, mouth rinses, and dental floss sold under brand names including Colgate, elmex, Tom's of Maine, and Sorriso. This segment serves both mass-market and premium natural products niches, addressing diverse consumer preferences across developed and emerging markets. Personal Care includes body wash, bar soap, deodorant, and shampoo products marketed under brands such as Palmolive, Softsoap, Irish Spring, Speed Stick, Lady Speed Stick, Sanex, and Protex. The Home Care division produces surface cleaners, fabric conditioners, and dishwashing liquids through brands like Ajax, Axion, Fabuloso, Soupline, and Suavitel, focusing on everyday household cleaning needs. The Pet Nutrition segment operates under the Hill's brand, offering Science Diet, Prescription Diet, and Ideal Balance products through veterinary channels and retail stores, targeting premium pet food markets with science-based formulations.

Colgate-Palmolive's business model centers on brand equity, distribution scale, and manufacturing efficiency. The company invests heavily in marketing to maintain top-of-mind awareness for its flagship brands, particularly Colgate toothpaste, which holds the number one global market share position in oral care. Distribution reaches consumers through multiple retail channels: supermarkets, mass merchandisers, warehouse clubs, drugstores, convenience stores, e-commerce platforms, veterinary clinics, and pet specialty retailers. Geographic diversification reduces dependence on any single market, with substantial revenue contributions from Latin America, Europe, Asia-Pacific, Africa, and North America.

The company generates revenue through direct sales to retailers and distributors, maintaining long-term relationships with major chains while also serving independent stores and specialty outlets. Pricing strategies vary by market segment, with premium positioning for brands like Tom's of Maine and Hill's Prescription Diet, while value-oriented brands compete on price-performance in emerging markets. Innovation focuses on incremental product improvements—new flavors, improved formulations, packaging enhancements—rather than breakthrough technologies, reflecting the mature nature of these consumer categories.

Manufacturing and Supply Chain

Production occurs across dozens of manufacturing facilities worldwide, enabling localized production that reduces shipping costs and tariff exposure while allowing formulation adjustments for regional preferences. The company manufactures many of its own raw materials and packaging components, controlling costs and ensuring consistent quality. Vertical integration extends to certain chemical inputs used in toothpaste and detergent formulations. Distribution networks leverage both company-owned warehousing and third-party logistics providers to reach millions of retail locations efficiently.

Competitive Landscape

The consumer products industry features intense competition from multinational corporations, regional brands, and private-label alternatives. In oral care, Colgate competes with Procter & Gamble's Crest brand, GlaxoSmithKline's Sensodyne, and numerous private-label offerings. Personal care and home care markets face competition from Unilever, Procter & Gamble, Reckitt Benckiser, and Henkel, among others. Pet nutrition sees competition from Mars Petcare, Nestlé Purina, and premium independent brands. Market share retention depends on sustained advertising spending, shelf space negotiation with retailers, and continuous product innovation to justify premium pricing over private-label alternatives.

Market Dynamics

Consumer products companies face ongoing pressure to demonstrate value propositions that justify brand premiums over generic alternatives. Retailer consolidation increases buyer power, compressing margins through promotional requirements and slotting fees. E-commerce growth shifts consumer purchasing behavior, requiring direct-to-consumer capabilities and subscription models. Sustainability expectations drive reformulations to reduce plastic packaging, eliminate certain chemicals, and source ingredients responsibly, creating both costs and differentiation opportunities. Emerging markets present growth opportunities through rising middle-class populations, though currency fluctuations and political instability create earnings volatility.

Dividend History and Capital Allocation

Colgate-Palmolive maintains a long-standing commitment to returning cash to shareholders through regular dividend payments, having increased its dividend consecutively for decades. This dividend growth record positions the stock as a holding for income-focused investors seeking stable consumer staples exposure. Capital allocation balances dividends, share repurchases, acquisitions of smaller brands or geographic expansion, and capital expenditures for manufacturing efficiency. The company typically generates strong free cash flow due to the low capital intensity of consumer products manufacturing and the recurring revenue nature of consumables that require repeat purchases.

Regulatory Environment

Consumer products companies operate under extensive regulatory oversight governing product safety, labeling accuracy, ingredient disclosure, environmental compliance, and advertising claims. The U.S. Food and Drug Administration regulates certain oral care and personal care products, while the Federal Trade Commission monitors advertising. International markets impose their own regulatory frameworks, requiring formulation adjustments and compliance investments. Prescription pet food products face veterinary regulations and require clinical testing to support therapeutic claims.

Strategic Considerations

The company's strategic priorities include defending market share in core oral care categories, growing penetration in emerging markets where oral hygiene adoption rates remain below developed market levels, expanding premium natural products offerings to capture consumer trends toward perceived healthier ingredients, and optimizing costs through manufacturing automation and procurement efficiency. Digital marketing and e-commerce capabilities receive increasing investment as consumer shopping behaviors shift online. Acquisitions typically focus on bolt-on brands that expand geographic reach or access growing consumer segments, rather than transformative mergers.

Stock Performance

$81.48
0.00%
0.00
Last updated: January 9, 2026 at 17:16
-5.65 %
Performance 1 year
$65.7B

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
2,474
Shares Sold
2
Transactions
Most Recent Transaction
Massey Sally (Chief Human Resources Officer) sold 1,237 shares @ $80.89 on Nov 21, 2025
Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

$20,101,000,000
Revenue (TTM)
$3,049,000,000
Net Income (TTM)
$4,107,000,000
Operating Cash Flow

Upcoming Events

JAN
21
January 21, 2026 Financial

Dividend record date

Shareholders of record on this date eligible for $0.52 quarterly dividend; contact investor_relations@colpal.com
FEB
13
February 13, 2026 Financial

Dividend payment date

Quarterly cash dividend $0.52 per share payable; details at www.colgatepalmolive.com

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Colgate Palmolive Co (CL)?

The current stock price of Colgate Palmolive Co (CL) is $81.48 as of January 11, 2026.

What is the market cap of Colgate Palmolive Co (CL)?

The market cap of Colgate Palmolive Co (CL) is approximately 65.7B. Learn more about what market capitalization means .

What is the revenue (TTM) of Colgate Palmolive Co (CL) stock?

The trailing twelve months (TTM) revenue of Colgate Palmolive Co (CL) is $20,101,000,000.

What is the net income of Colgate Palmolive Co (CL)?

The trailing twelve months (TTM) net income of Colgate Palmolive Co (CL) is $3,049,000,000.

What is the earnings per share (EPS) of Colgate Palmolive Co (CL)?

The diluted earnings per share (EPS) of Colgate Palmolive Co (CL) is $3.51 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Colgate Palmolive Co (CL)?

The operating cash flow of Colgate Palmolive Co (CL) is $4,107,000,000. Learn about cash flow.

What is the profit margin of Colgate Palmolive Co (CL)?

The net profit margin of Colgate Palmolive Co (CL) is 15.17%. Learn about profit margins.

What is the operating margin of Colgate Palmolive Co (CL)?

The operating profit margin of Colgate Palmolive Co (CL) is 21.23%. Learn about operating margins.

What is the gross margin of Colgate Palmolive Co (CL)?

The gross profit margin of Colgate Palmolive Co (CL) is 60.50%. Learn about gross margins.

What is the current ratio of Colgate Palmolive Co (CL)?

The current ratio of Colgate Palmolive Co (CL) is 0.92, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Colgate Palmolive Co (CL)?

The gross profit of Colgate Palmolive Co (CL) is $12,161,000,000 on a trailing twelve months (TTM) basis.

What is the operating income of Colgate Palmolive Co (CL)?

The operating income of Colgate Palmolive Co (CL) is $4,268,000,000. Learn about operating income.

What products does Colgate-Palmolive manufacture?

Colgate-Palmolive manufactures four main product categories: oral care (toothpaste, toothbrushes, mouth rinses), personal care (body wash, soap, deodorant), home care (surface cleaners, fabric conditioners, dishwashing liquid), and pet nutrition (Science Diet and Prescription Diet pet foods). These products are sold under globally recognized brand names across more than 200 countries.

How does Colgate-Palmolive generate revenue?

The company generates revenue through direct sales to retailers and distributors worldwide, including supermarkets, mass merchandisers, drugstores, e-commerce platforms, and pet specialty stores. Revenue comes from repeat purchases of consumable products that require regular replacement, creating recurring income streams. Geographic diversification across North America, Latin America, Europe, Asia-Pacific, and Africa reduces dependence on any single market.

What is Colgate-Palmolive's largest business segment?

Oral care represents Colgate-Palmolive's largest and most profitable business segment, driven primarily by the Colgate toothpaste brand which holds the number one global market share position. This segment includes toothpaste, toothbrushes, mouth rinses, and dental floss sold under multiple brand names targeting different market segments and price points.

Who are Colgate-Palmolive's main competitors?

In oral care, Colgate competes primarily with Procter & Gamble's Crest and GlaxoSmithKline's Sensodyne. Personal care and home care face competition from Unilever, Procter & Gamble, Reckitt Benckiser, and Henkel. Pet nutrition competes against Mars Petcare and Nestlé Purina. Private-label brands also compete across all categories by offering lower-priced alternatives.

What is Hill's Pet Nutrition?

Hill's is Colgate-Palmolive's pet nutrition division, offering Science Diet for everyday nutrition, Prescription Diet for therapeutic veterinary formulas, and Ideal Balance products. Hill's targets the premium pet food segment with science-based formulations developed through clinical research. Products are sold through veterinary clinics, pet specialty retailers, and mass-market channels.

How does Colgate-Palmolive distribute its products globally?

The company operates manufacturing facilities worldwide to enable localized production, reducing shipping costs and allowing regional formulation adjustments. Distribution reaches consumers through multiple retail channels using both company-owned warehousing and third-party logistics providers. This global infrastructure allows the company to serve millions of retail locations across diverse markets efficiently.

What makes Colgate-Palmolive attractive to dividend investors?

Colgate-Palmolive has increased its dividend consecutively for decades, earning recognition as a dividend aristocrat. The company generates strong free cash flow from its consumables business model, where products require repeat purchases. This reliable cash generation supports consistent dividend growth, making the stock popular among income-focused investors seeking exposure to defensive consumer staples.

What role do emerging markets play in Colgate-Palmolive's business?

Emerging markets represent significant growth opportunities as rising middle-class populations increase demand for branded oral care and household products. The company maintains substantial operations across Latin America, Asia-Pacific, and Africa, though these markets also introduce currency fluctuation risks and political uncertainties that can create earnings volatility.

How does Colgate-Palmolive compete against private-label brands?

The company invests heavily in brand marketing to maintain consumer preference and justify premium pricing over private-label alternatives. Colgate defends market share through continuous product innovation, sustained advertising spending, and shelf space negotiation with retailers. Strong brand equity built over decades helps retain customers despite lower-priced generic options.

What regulatory oversight does Colgate-Palmolive face?

The company operates under extensive regulatory frameworks governing product safety, ingredient disclosure, labeling accuracy, and advertising claims. The FDA regulates certain oral care and personal care products in the United States, while international markets impose their own requirements. Hill's Prescription Diet products face veterinary regulations requiring clinical testing to support therapeutic claims.